Succinate-treated macrophages attenuate dextran sodium sulfate colitis in mice
- PMID: 33120440
- PMCID: PMC8322029
- DOI: 10.5217/ir.2020.00075
Succinate-treated macrophages attenuate dextran sodium sulfate colitis in mice
Abstract
The safety and effectiveness of adalimumab was demonstrated in a phase 3 trial in Japanese patients with intestinal Behçet's disease. The aim of this study was to evaluate the long-term safety and effectiveness of adalimumab in Japanese patients with intestinal Behçet's disease.
Conflict of interest statement
Cheon JH is an editorial board member of the journal but was not involved in the peer reviewer selection, evaluation, or decision process of this article. No other potential conflicts of interest relevant to this article were reported.
Figures
References
-
- Macias-Ceja DC, Ortiz-Masiá D, Salvador P, et al. Succinate receptor mediates intestinal inflammation and fibrosis. Mucosal Immunol. 2019;12:178–187. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
